BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33002420)

  • 1. Recurrent ZNF83-E293V Mutation Promotes Bladder Cancer Progression through the NF-κB Pathway via Transcriptional Dysregulation of S100A8.
    Lyu ZJ; Wang Y; Huang JL; Chen M; Wu SY; Yan Q; Zhang Y; Tang Y; Jiang C; Li L; Jia YZ; Liu YC; Mei HB; Wang F; Li RH; Chen YC; Lin X; Cai ZM; Guan XY
    Mol Ther; 2021 Jan; 29(1):275-290. PubMed ID: 33002420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Fezf2 promotes malignant progression of bladder cancer by regulating the NF-κB signaling pathway.
    Chen Z; Zhou L; Liu X; Wang L; Kazobinka G; Zhang X; Hou T
    Lab Invest; 2018 Sep; 98(9):1225-1236. PubMed ID: 29925938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
    Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
    Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.
    Cui X; Shen D; Kong C; Zhang Z; Zeng Y; Lin X; Liu X
    Sci Rep; 2017 Jan; 7():40723. PubMed ID: 28139689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer.
    Mukherjee N; Cardenas E; Bedolla R; Ghosh R
    Oncotarget; 2017 Feb; 8(9):15114-15125. PubMed ID: 28122346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High NF-κB and STAT3 activity in human urothelial carcinoma: a pilot study.
    Degoricija M; Situm M; Korać J; Miljković A; Matić K; Paradžik M; Marinović Terzić I; Jerončić A; Tomić S; Terzić J
    World J Urol; 2014 Dec; 32(6):1469-75. PubMed ID: 24448750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8.
    Karashima T; Sweeney P; Kamat A; Huang S; Kim SJ; Bar-Eli M; McConkey DJ; Dinney CP
    Clin Cancer Res; 2003 Jul; 9(7):2786-97. PubMed ID: 12855659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C-α (PKCα) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder.
    Zheng J; Kong C; Yang X; Cui X; Lin X; Zhang Z
    BMC Cancer; 2017 Jun; 17(1):432. PubMed ID: 28629334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
    Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
    Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis.
    Németh J; Stein I; Haag D; Riehl A; Longerich T; Horwitz E; Breuhahn K; Gebhardt C; Schirmacher P; Hahn M; Ben-Neriah Y; Pikarsky E; Angel P; Hess J
    Hepatology; 2009 Oct; 50(4):1251-62. PubMed ID: 19670424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling.
    Wu Q; Zhou X; Li P; Ding M; You S; Xu Z; Ye J; Chen X; Tan M; Wang J; Wang W; Qiu J
    J Exp Clin Cancer Res; 2021 May; 40(1):158. PubMed ID: 33962660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-κB signaling.
    Li G; Wang M; Ren L; Li H; Liu Q; Ouyang Y; He L; Li F
    Biomed Pharmacother; 2019 Sep; 117():109112. PubMed ID: 31212130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma.
    Wen H; Ma H; Cai Q; Lin S; Lei X; He B; Wu S; Wang Z; Gao Y; Liu W; Liu W; Tao Q; Long Z; Yan M; Li D; Kelley KW; Yang Y; Huang H; Liu Q
    Nat Med; 2018 Feb; 24(2):154-164. PubMed ID: 29291352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
    Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
    Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RIPK4 promotes bladder urothelial carcinoma cell aggressiveness by upregulating VEGF-A through the NF-κB pathway.
    Liu JY; Zeng QH; Cao PG; Xie D; Chen X; Yang F; He LY; Dai YB; Li JJ; Liu XM; Zeng HL; Zhu YX; Gong L; Cheng Y; Zhou JD; Hu J; Bo H; Xu ZZ; Cao K
    Br J Cancer; 2018 Jun; 118(12):1617-1627. PubMed ID: 29867225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-κB-modulated tumor progression in bladder cancer in vitro and in vivo.
    Chiang CH; Chung JG; Hsu FT
    Environ Toxicol; 2019 Jun; 34(6):679-688. PubMed ID: 30801954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A8/A9 activate key genes and pathways in colon tumor progression.
    Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
    Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathway.
    Huang Z; Zhong Z; Zhang L; Wang X; Xu R; Zhu L; Wang Z; Hu S; Zhao X
    Sci Rep; 2015 Aug; 5():12807. PubMed ID: 26239046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
    Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
    J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression.
    Cui X; Kong C; Zhu Y; Zeng Y; Zhang Z; Liu X; Zhan B; Piao C; Jiang Z
    Oncotarget; 2016 Jul; 7(30):48547-48561. PubMed ID: 27391066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.